For the Inventor, By the Inventor

Enter assignee name

Fort Worth, TX, United States of America

Alcon Laboratories, Inc.

USPTO Granted Patents = 449

CIPO Patents = 3

EPO Patents = 2

Trademarks = 101

Forward Citations = 19,626

Loading Chart...

Loading Chart...

333 inventors (with patents filed for the assignee):

Mark R Hellberg (32 out of 89 patents)

Billie M York (25 out of 29 patents)

Abbot F Clark (20 out of 58 patents)

4. Bahram Asgharian (19 out of 35 patents)

5. Verney L Sallee (19 out of 22 patents)

6. Stella M Robertson (19 out of 19 patents)

7. Thomas R Dean (18 out of 26 patents)

8. John M Yanni (16 out of 53 patents)

9. Raymond E Conrow (15 out of 29 patents)

10. Bor-Shyue Hong (15 out of 16 patents)

11. Joonsup Park (15 out of 20 patents)

12. Louis DeSantis, Jr (14 out of 20 patents)

13. Masood A Chowhan (13 out of 41 patents)

14. Paul W Zinke (13 out of 21 patents)

15. Ronald P Quintana (13 out of 13 patents)

Core Competencies:

Ophthalmic Compositions

Glaucoma Treatment

Contact Lens Care

Sustained Release Antibiotics

Intraocular Lens

Neuroprotective Agents

Prostaglandin Analogues

Ocular Therapy

Test Devices

Surgical Handpieces

Retinal Disorders

Liquid Enzyme Compositions

449 patents: Sort by Forward Citations

1. 9078887 - Bicyclic heteroaryl inhibitors of PDE4 (2015-07-14),

2. 6890484 - In line test device and methods of use (2005-05-10),

3. 6863073 - Laminar cribosa puncture device, methods related to use of such a device and methods for treating central retinal vein occulsions (2005-03-08),

4. 6759190 - Test strip for detection of analyte and methods of use (2004-07-06),

5. 6630135 - Use of sustained release antibiotic compositions in ophthalmic surgical procedures (2003-10-07),

6. 6565808 - Line test device and methods of use (2003-05-20),

7. 6509355 - Treatment of disorders of the outer retina (2003-01-21),

8. D468437 - Test platform (2003-01-08),

9. 6486208 - Sustained release, and comfortable opthalmic composition and method for ocular therapy (2002-11-26),

10. D464141 - Test device platform (2002-10-09),

11. 6403590 - Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia (2002-06-11),

12. 6399107 - Use of inhibitors of gag synthesis for the treatment of corneal haze (2002-06-04),

13. 6358897 - Alkyl trypsin compositions and methods of use in contact lens cleaning and disinfecting systems (2002-03-19),

14. 6353014 - 15-ketal postaglandins for the treatment of glaucoma or ocular hypertension (2002-03-05),

15. 6353000 - 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension (2002-03-05),

Alcon Laboratories, Inc. is a global leader in eye care, providing innovative products that enhance quality of life by helping people see better. They offer a wide range of surgical, pharmaceutical, and vision care products. With a mission to advance eye health worldwide, Alcon strives to continuously introduce breakthrough technologies and deliver exceptional patient care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

449 Patents

#2 in Fort Worth, TX

#63 in Texas

#1,025 in US

#2,053 in the World

Fort Worth, TX, United States of America

Alcon Laboratories, Inc.

Forward Citations = 19,626

333 inventors:

Mark R Hellberg (32 out of 89 patents)

Billie M York (25 out of 29 patents)

Abbot F Clark (20 out of 58 patents)

4. Bahram Asgharian (19 out of 35 patents)

5. Verney L Sallee (19 out of 22 patents)

Please report any incorrect information to support@idiyas.com

Loading…